Protective efficacy of an IL-12-expressing baculoviral malaria vaccine

Parasite Immunology
Mitsuhiro IyoriShigeto Yoshida

Abstract

Interleukin-12 (IL-12) plays an important role in antigen-specific adaptive immunity against Plasmodium sporozoites, and this requirement allows for a new approach to developing an effective malaria vaccine. In this study, we examined whether IL-12 could enhance protective efficacy of a baculovirus-based malaria vaccine. For this aim, a baculoviral vector expressing murine IL-12 (mIL-12) under the control of CMV promoter (BES-mIL-12-Spider) and a baculoviral vector expressing Plasmodium falciparum circumsporozoite protein (PfCSP) with post-transcriptional regulatory element of woodchuck hepatitis virus (BDES-sPfCSP2-WPRE-Spider) were generated. BES-mIL-12-Spider produced bioactive IL-12 which activates splenocytes, resulting in induction of IFN-γ. When co-immunized with BES-mIL-12-Spider and BDES-sPfCSP2-WPRE-Spider, the mouse number for high IgG2a/IgG1 ratios and the geometric mean in this group were both increased as compared with those of the other groups, indicating a shift towards a Th1-type response following immunization with BES-mIL-12-Spider. Finally, immunization with BDES-sPfCSP2-WPRE-Spider plus BES-mIL-12-Spider had a higher protective efficacy (73%) than immunization with BDES-sPfCSP2-WPRE-Spider alone (30%) again...Continue Reading

References

Oct 31, 1996·Nature·A K AbbasA Sher
Feb 4, 2003·Nature Reviews. Immunology·Giorgio Trinchieri
Jun 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sanjay GargJoshy Jacob
Jul 10, 2007·Journal of Biotechnology·Anssi J MähönenSeppo Ylä-Herttuala
Dec 28, 2007·Infection and Immunity·Giane A OliveiraElizabeth H Nardin
Oct 30, 2010·Immunity·Michael F Good, Denise L Doolan
Jan 22, 2014·Journal of Biotechnology·Jingping GeWenxiang Ping
Aug 27, 2014·Expert Review of Vaccines·Shih-Yeh LinYu-Chen Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.